Morphologic/Neurochemical Correlates of Depression in AD
Morphologic/Neurochemical Correlates of Depression in AD
批准号:
7535200
负责人:
GEORGE S ZUBENKO
金额:
$63.41万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2010-11-30
关键词:
AffectAgeAllelesAlzheimer&aposs DiseaseApolipoprotein EApoptosisApoptoticAreaAutopsyBasal Nucleus of MeynertBehaviorBehavioralBiologicalBiological PreservationBiologyBrainBrain StemBrain regionCell DeathCell NucleusCellsCessation of lifeCholine O-AcetyltransferaseChromatinClinicalClinical assessmentsCollaborationsComplicationDNADNA FragmentationDNA Repair EnzymesDataDelusionsDementiaDevelopmentDiagnosisDiagnosticDopamineDorsalElderlyElementsEventFamilyFamily history ofFirst Degree RelativeFreezingFrequenciesFundingGenotypeGeriatric PsychiatryGoalsHallucinationsHigh Pressure Liquid ChromatographyHigh PrevalenceHippocampus (Brain)HourIncidenceInstitutionalizationIntentionInterviewLeadLeftLewy BodiesLongitudinal StudiesMajor Depressive DisorderMeasuresMethodsMood DisordersNational Institute of Mental HealthNatureNeocortexNerve DegenerationNeuronsNeurotransmittersNorepinephrineNuclearOutpatientsPathogenesisPathway interactionsPatientsPerceptionPhysical condensationPredispositionPrevalenceProcessProgress ReportsProteinsPsychotic DisordersQualifyingRecording of previous eventsRecruitment ActivityRecurrenceRelative (related person)ReportingResearchResearch PersonnelResearch Project GrantsRoleSamplingSenile PlaquesSerotoninSeveritiesSiteSpecificityStochastic ProcessesStructureSubstantia nigra structureSymptomsSyndromeTimeTissue SampleTissuesUnited StatesUp-RegulationVariantcaregivingcase controlcholinergicclinical materialdensitydepressiondepressive symptomsdisabilitydisorder controldisturbance in affecteffective therapyexperiencegeriatric depressioninsightknowledge baseneurochemistryneuron lossnormal agingpreventprogramssingle episode major depressive disorder
中文摘要
描述(申请人提供):严重抑郁障碍(MDD)是阿尔茨海默病(AD)的一种常见和重要的并发症,它增加了患者及其家人的痛苦,产生了过度的残疾,促进了制度化,并加速了死亡。阿尔茨海默病的临床病理研究表明,阿尔茨海默病的这种行为并发症的发生与脑干氨基核(SN、DR、LC)的变性和胆碱能BNM的相对保存有关。AD+MDD的这些神经病理和相关的神经化学相关性似乎对AD的这一行为并发症具有相对特异性,并可能在这一背景下解释MDD的病程和治疗反应的某些方面。
我们建议使用125例经组织病理学证实的AID病例和对照来评估这一主要病因学假说,这些病例和对照的特征是由NIA资助的四个ADRC和NIMI-T老年精神病学分支机构组成的联合体。所有参与网站都采用了痴呆症抑郁临床评估(CADD),这是一种结构化的、支撑性的诊断访谈,旨在可靠地诊断和描述这项正在进行的纵向研究中的严重抑郁发作(MDE)。使用免疫染色连续切片的严格体视学分析对脑干核团的神经退行性变进行多维评估,并使用闪存冰冻组织样本按照建立的高效液相色谱方法测定确定的皮质和皮质下投影区的NTS/代谢物。
第二位。假说探索:a)临床亚型与这些神经病理和神经化学变量的关系,b)这些区域细胞死亡的机制,c)MDD家族史和APOE基因对AD中MDD发生的影响。
拟议研究计划的长远目标是更好地界定AD中MDD的生物底物,目的是增加知识基础,促进开发更有效的治疗方法,并对影响老年人的主要情绪障碍的临床生物学提供更多见解。
英文摘要
DESCRIPTION (provided by applicant): Major Depressive Disorder (MDD) is a common and important complication of Alzheimer's disease (AD) that increases the suffering of patients and their families, produces excess disability, promotes institutionalization, and hastens death. Emerging clinicopathological studies of MDD in AD suggest that the development of this behavioral complication of AD is associated with degeneration of the brainstem aminergic nuclei (SN, DR, LC) and the relative preservation of the cholinergic bnM. These neuropathologic and related neurochemical correlates of AD+MDD appear to be relatively specific for this behavioral complication of AD, and may explain aspects of the course and treatment responsiveness of MDD in this context.
We propose to evaluate this primary etiologic hypothesis using 125 histopathologically-confirmed AID cases and controls who were prospectively characterized by a consortium of four NIA-funded ADRCs and the Geriatric Psychiatry Branch, DIRP, NIMI-t. All participating sites employ the Clinical Assessment of Depression in Dementia (CADD), a structured, anchored diagnostic interview that was developed to reliably diagnose and characterize Major Depressive Episodes (MDEs) in this ongoing longitudinal study. Multidimensional assessments of neurodegeneration of the brainstem nuclei are performed using rigorous stereologic analyses of immunostained frozen serial sections, and determinatons of NTs/metabolites in defined cortical and subcortical projection areas are performed using flash-frozen tissue samples by established HPLC methods.
Secondary. Hypotheses explore: a) the associations of clinical subtypes on these neuropathologic and neurochemical variables, b) the mechanism of cell death in these regions, and c) the influence of a family history of MDD and APOE genotype on the emergence of MDD in AD.
The long-term goal of the proposed research plan is to better define the biological substrates MDD in AD, with the intention of augmenting the knowledge base that will facilitate the development of more effective treatments, and to provide additional insight into the clinical biology of Major Mood Disorders affecting the elderly.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
No evidence of non-homologous insertions in mouse model of MDD created by replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence.
没有证据表明 MDD 小鼠模型中存在非同源插入,该模型是通过用致病性 6 碱基人 CREB1 启动子序列替换同源小鼠 DNA 序列而创建的。
DOI:
10.1002/ajmg.b.32006
发表时间:
2012
期刊:
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
影响因子:
--
作者:
[Zubenko,GeorgeS, Hughes3rd,HughB]
通讯作者:
Hughes3rd,HughB
DOI:
10.1002/ajmg.b.31197
发表时间:
2011-07
期刊:
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
影响因子:
2.8
作者:
[Zubenko, George S., Hughes, Hugh B., III]
通讯作者:
Hughes, Hugh B., III
DOI:
10.1002/ajmg.b.32257
发表时间:
2014-09
期刊:
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
影响因子:
2.8
作者:
[Zubenko, George S., Hughes, Hugh B., Jordan, Rick M., Lyons-Weiler, James, Cohen, Bruce M.]
通讯作者:
Cohen, Bruce M.
GENETICS OF RECURRENT EARLY ONSET DEPRESSION (GENRED)
-
批准号:6041956
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1999
-
负责人:GEORGE S ZUBENKO
-
依托单位:
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
-
批准号:6186938
-
项目类别:
-
资助金额:$29.81万
-
财政年份:1999
-
负责人:GEORGE S ZUBENKO
-
依托单位:
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
-
批准号:6392700
-
项目类别:
-
资助金额:$37.45万
-
财政年份:1999
-
负责人:GEORGE S ZUBENKO
-
依托单位:
BIOLOGICAL MARKERS FOR PRIMARY DEMENTIA IN ELDERLY
-
批准号:6221115
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1999
-
负责人:GEORGE S ZUBENKO
-
依托单位:
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
-
批准号:6528615
-
项目类别:
-
资助金额:$37.64万
-
财政年份:1999
-
负责人:GEORGE S ZUBENKO
-
依托单位:
BIOLOGICAL MARKERS FOR PRIMARY DEMENTIA IN ELDERLY: ALZHEIMERS
-
批准号:6253471
-
项目类别:
-
资助金额:$0.61万
-
财政年份:1997
-
负责人:GEORGE S ZUBENKO
-
依托单位:
PILOT--FUNCTIONAL CORRELATES OF SUBCORTICAL WHITE MATTER LESIONS
-
批准号:6111628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1996
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
-
批准号:2430938
-
项目类别:
-
资助金额:$42.01万
-
财政年份:1993
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
-
批准号:3388476
-
项目类别:
-
资助金额:$31.16万
-
财政年份:1993
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
-
批准号:2248523
-
项目类别:
-
资助金额:$35.01万
-
财政年份:1993
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
-
批准号:2033906
-
项目类别:
-
资助金额:$40.51万
-
财政年份:1993
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
-
批准号:2248522
-
项目类别:
-
资助金额:$31.16万
-
财政年份:1993
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:2247563
-
项目类别:
-
资助金额:$24.32万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:3387181
-
项目类别:
-
资助金额:$21.81万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:6391985
-
项目类别:
-
资助金额:$43.37万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:3387182
-
项目类别:
-
资助金额:$22.19万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
Morphologic/Neurochemical Correlates of Depression in AD
-
批准号:6867042
-
项目类别:
-
资助金额:$71.58万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
Morphologic/Neurochemical Correlates of Depression in AD
-
批准号:7147451
-
项目类别:
-
资助金额:$64.13万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:2247562
-
项目类别:
-
资助金额:$23.32万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
MORPHOLOGIC/NEUROCHEMICAL CORRELATES OF DEPRESSION IN AD
-
批准号:6186315
-
项目类别:
-
资助金额:$35.41万
-
财政年份:1992
-
负责人:GEORGE S ZUBENKO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: